We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.46 | -0.93% | 49.00 | 49.00 | 49.95 | 49.595 | 48.97 | 49.48 | 1,113,911 | 01:00:00 |
From May 2019 to May 2024
By Anthony Shevlin
Sanofi SA (SAN.FR) said Tuesday that it has proposed to reappoint its Chief Executive Olivier Brandicourt and two other directors to the board of directors, as well as appoint Emmanuel Babeau as a new independent director.
The company said there would be a vote on the positions at the general shareholders' meeting on May 2.
It has also proposed to reappoint directors Patrick Kron and Christian Mulliez to its board of directors.
Sanofi said Robert Castaigne, board member since 2000 and current chair of the audit committee, will not seek a new term. Fabienne Lecorvaisier will succeed him, said the company.
The board has also created a new scientific committee, which will be led by Thomas Suedhof, said Sanofi.
Write to Anthony Shevlin at anthony.shevlin@dowjones.com
(END) Dow Jones Newswires
March 06, 2018 10:42 ET (15:42 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
